Taste and smell perception and quality of life during and after systemic therapy for breast cancer.
Renate M WinkelsS BoesveldtC S KelfkensE E PosthumaM M G A van den BergJ Th C M de KruifA HaringhuizenD W SommeijerN BuistS GrosfeldC de GraafH W M van LaarhovenE KampmanR M WinkelsPublished in: Breast cancer research and treatment (2018)
Most taste and smell alterations recovered within 6 months after the end of chemotherapy for breast cancer, but not for patients receiving trastuzumab. These results highlight the importance of monitoring taste and smell alterations during and after treatment with chemotherapy and trastuzumab, as they may impact quality of life.